Combination drug

Details Combination drug Combination drug

A - Human Necessities

61

K

A61K 45/06 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/427 (2006.01) A61K 31/44 (2006.01) A61K 31/4439 (2006.01) A61P 1/04 (2006.01) A61P 19/02 (2006.01) A61P 29/00 (2006.01) C07D 263/44 (2006.01) C07D 277/34 (2006.01) C07D 413/06 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2399463

A TNF-.alpha. inhibitor comprising a combination of an insulin resistance- ameliorating agent with an HMG-CoA reductase inhibitor which is useful as a preventive or a remedy for inflammatory diseases, etc.

La présente invention concerne un inhibiteur de facteur de nécrose tumorale .alpha. qui comprend une combinaison constituée d'un agent d'amélioration de la résistance à l'insuline et d'un inhibiteur de réductase HMG-CoA et qui est utilisé dans la prévention ou le traitement de maladies inflammatoires, etc.

Affiliated with

Also associated with

Rating

Combination drug does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination drug will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2060672